abstract |
The invention relates to the use of 8-cyano-1-cyclopropyl- 6-fluoro-7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and its pharmaceutically usable hydrates and/ or salts, their use for production of medicaments for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases. |